General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows

v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash Flows From Operating Activities        
Net (Loss) Income $ (4,762,078) $ 1,563,713 $ (38,726,259) $ (20,324,648)
Stock-based compensation        
Shares issued for services 149,718 331,591 2,148,889
Amortization of stock options and restricted stock units 557,421 596,467 2,633,826 2,852,309
Impairment of goodwill     33,547,278
Impairment of IP R&D assets     3,342,084  
Amortization of intangibles 21,772 26,462 109,004 109,947
Bad debt expense - related parties     300,000
Gain on settlement of liabilities, net     (926,829)
Loss on extinguishment of convertible note payable     9,737
Deferred tax benefit (22,332) (942,749) (24,803)
Offering costs allocated to warrant liabilities     604,118
Change in fair value of derivative liabilities (53,323) (5,230,114) (15,144,986) 4,677,388
Change in fair value of accrued issuable equity (17,520) 9,405
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets 424,913 (325,057) 1,018,303 (1,377,247)
Accounts payable (621,861) 454,982 1,214,599 (5,515,042)
Accounts payable – related parties     (215,495)
Accrued expenses 526,367 662,880 319,936 (1,210,076)
Accrued expenses – related parties 36,898 19,270 169,788 (436,581)
Accrued issuable equity 48,600 (52,500)
Total adjustments 892,187 (3,636,644) 26,598,674 953,220
Net Cash Used In Operating Activities (3,869,891) (2,072,931) (12,127,585) (19,371,428)
Cash Flows From Financing Activities        
Shares issued for cash, net of issuance costs     26,666,200
Offering costs in connection with 2021 sale of stock and warrants     (2,055,130)
Offering costs in connection with July 2022 sale of common stock and common stock warrants     (529,982)
Offering costs in connection with December 2022 sale of common stock and common stock warrants     (484,991)
Proceeds from loans payable     1,060,890 1,618,443
Repayment of convertible debt – related parties     (10,000)
Repayment of loans payable, net of adjustments (Note 9)     (1,591,035) (375,789)
Repayment of loans payable – related parties     (81,277) (431,805)
Proceeds from sale of July 2022 common stock and common stock warrants     6,499,737
Proceeds from sale of December 2022 common stock and common stock warrants     5,999,851
Proceeds from exercise of July 2022 pre-funded warrants     263
Proceeds from exercise of December 2022 pre-funded warrants     150
Repayment of loans payable (469,810) (515,419)    
Net Cash Used In Financing Activities (469,810) (515,419) 10,873,606 25,411,919
Effect of Exchange Rate Changes on Cash 15,775 32,757 (419) 75,473
Net Decrease In Cash (4,323,926) (2,555,593) (1,254,398) 6,115,964
Cash - Beginning of Period 6,970,110 8,224,508 8,224,508 2,108,544
Cash - End of Period 2,646,184 5,668,915 6,970,110 8,224,508
Supplemental Disclosures of Cash Flow Information:        
Cash paid during the period for income taxes
Cash paid during the period for interest $ 7,265 $ 2,853 15,060 35,351
Non-cash investing and financing activities:        
Common stock issued upon conversion of KBL debt     1,931,388
Common stock issued upon conversion of 180 debt     432,383
Common stock issued in connection with repayment of related party loans and convertible notes     851,112
Shares and warrants issued for Alpha Settlement     1,013,331
Exchange of common stock equivalents for common stock     146
Shares issued to settle accounts payable     1,750,000
Reclassification of accrued issuable equity     $ 43,095